IVVD
IVVD
NASDAQ · Biotechnology

Invivyd Inc

Small-Cap Stocks Penny Stocks Biotech Stocks Healthcare Stocks
$1.51
+0.08 (+5.59%)
As of May 9, 1:50 AM ET ·
Analyst Consensus
Strong Buy
10
Analysts
Moderate
Coverage
Buy 8 80%
Hold 2 20%
Sell 0 0%
Price Target
Analyst Price Target +1,322.5% upside
Low Target $15.01
Average Target $21.48
High Target $34.49
Current Price $1.51
Current
$1.51
Target
$21.48
$15.01 $21.48 avg $34.49
Scenario Analysis
Bear Case
$15.01
894.0%
Low target
Base Case
$21.48
+1,322.5%
Avg target
Bull Case
$34.49
+2,184.1%
High target
Risk/Reward
2.4x
Favorable
Price in Context
52-Week High
$3.07
-50.8% from high
52-Week Low
$0.48
+212.6% from low
Target vs 52W High
$21.48
+599.7% vs high
Next Earnings Report
May 14, 2026
3d
until earnings
EPS Est: $-0.07
Earnings in 3 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 75% $257.58 +27.8%
AMGN
Amgen Inc
 Hold 44 48% $190.87 -42.5%
GILD
Gilead Sciences Inc
 Strong Buy 39 79% $362.68 +176.2%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 79% $438.34 +2.0%
REGN
Regeneron Pharmaceuticals
 Strong Buy 38 79% $76.80 -89.3%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 75% $102.31 -65.3%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -19.5%
INSM
Insmed Inc
 Strong Buy 28 96% $143.40 +41.5%